Compare Globalstar (GSAT) vs Roivant Sciences Ltd. Common Shares (ROIV) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Globalstar vs Roivant Sciences Ltd. Common Shares — how do they compare? Globalstar trades at $83.82 (market cap $10.78B), while Roivant Sciences Ltd. Common Shares trades at $35.44 (market cap $24.72B). The key difference: Roivant Sciences Ltd. Common Shares is far larger — about 2.3× Globalstar's market cap, and Globalstar is trading nearer its 52-week high, Roivant Sciences Ltd. Common Shares nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Globalstar for 21 Days and Roivant Sciences Ltd. Common Shares for 1 Days on average.
| GSAT | ROIV | |
|---|---|---|
Market Cap | $10.78B | $24.72B |
Volume | 723,953 | 6,279,442 |
Sector | Media | Health |
52-Week High | $84.43 | $41.81 |
52-Week Low | $41.54 | $16.04 |
Typical Hold Time | 21 Days | 1 Days |
Enterprise Value | $10.79B | $20.99B |
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About Globalstar
Globalstar provides satellite and terrestrial connectivity services, including voice, data, asset tracking, and private wireless solutions. It operates a low-Earth-orbit satellite network and holds licensed mid-band spectrum.
Read more on GSAT →About Roivant Sciences Ltd. Common Shares
Roivant Sciences develops medicines by building and supporting biotechnology subsidiaries, known as Vants. Its programs span areas such as immunology, neuroscience, and rare diseases.
Read more on ROIV →
